Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis
Authors
- Gwen Wilson (ORCID: https://orcid.org/0000-0002-7214-0403)
- Idil Tarikogullari (ORCID: https://orcid.org/0000-0003-0015-4707)
- Jennifer L. Vande Voort (ORCID: https://orcid.org/0000-0002-3630-4773)
- Balwinder Singh (ORCID: https://orcid.org/0000-0001-7062-8192)
- Simon Kung (ORCID: https://orcid.org/0000-0002-2959-8312)
- Mark A. Frye (ORCID: https://orcid.org/0000-0003-3277-3094)
- Ahmed Elmosalamy (ORCID: https://orcid.org/0000-0001-6935-6089)
- Liliana Patarroyo-Rodríguez (ORCID: https://orcid.org/0000-0002-8822-699X)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Therapeutic Advances in Psychopharmacology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1177/20451253251394127
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39